| Ytd | 50.70% | |
| 1y | 305.32% |
| Open | 23.45 | Prev Close | 23.48 | Low | 23.40 | High | 24.23 | Mkt Cap | 1.54B |
| Vol | 777.09K | Avg Vol | 1.16M | EPS | -1.47 | P/E | -16.07 | Forward P/E | 10.02 |
| Beta | 1.56 | Short Ratio | 11.61 | Inst. Own | 113.24% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 20.28 | 200-d Avg | 17.62 | 1yr Est | 33.17 |
Guggenheim analyst Michael Schmidt maintains Monte Rosa Therapeutics (NASDAQ:GLUE) with a Buy and
On Monday, 369 companies set new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.